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Abstract: 33 
Introduction: Evaluating complex dietary interventions such as Mediterranean diet in 34 
pregnancy presents unique methodological challenges. We present the challenges and the 35 
lessons learned from a multicentre randomised trial (ESTEEM) on Mediterranean-based 36 
dietary intervention in pregnancy.  37 
Methods: We recruited pregnant women who met our predefined inclusion criteria and 38 
randomised those with metabolic risk factors to the Mediterranean-based dietary intervention 39 
or routine antenatal care. We evaluated the effect of the ESTEEM intervention on composite 40 
maternal and fetal outcomes.  41 
Challenges and solutions: The main challenges were encountered in recruiting to ESTEEM, 42 
delivering the intervention, engaging clinical staff, assessing adherence and choosing the 43 
outcome measures. The large sample size coupled with the slow recruitment rate forced us to 44 
extend the recruitment period by 4 months. The limitation in available resources was 45 
overcome by opening sites in a step-wise approach. Engaging healthcare providers was 46 
promoted by embedding the recruitment and the follow-up activities into current clinical 47 
practice, and promoting research skills training. We delivered the intervention early on in the 48 
pregnancy to promote the dietary effect on healthy placentation and reduce metabolic risk 49 
factors. Participants and their families were actively involved in the dietary intervention to 50 
improve adherence through a series of group teaching sessions. A user-friendly short dietary 51 
questionnaire was developed and validated to assess adherence to the intervention. The trial 52 
composite primary outcome was chosen in consensus based on input from a panel of experts. 53 
Conclusion: The ESTEEM experience offers an insight into future pragmatic nutritional 54 
studies in pregnancy. 55 
 56 
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Introduction: 57 
Women with metabolic risk factors such as high BMI, dyslipidaemia and chronic 58 
hypertension are at increased risk of developing adverse outcomes such as gestational 59 
diabetes, pre-eclampsia and admissions to neonatal intensive care units.(1) With the rapidly 60 
increasing number of women entering pregnancy as obese or overweight, researchers are 61 
more focused on evaluating the role of dietary and lifestyle interventions to improve maternal 62 
and fetal health outcomes.(2)  63 
 64 
Mediterranean based diet has been shown to improve cardiovascular outcomes in a non-65 
pregnant population.(3,4) The effect of such diet on pregnancy outcomes in women with 66 
metabolic risk factors is not known.(5,6) Evaluating complex dietary interventions such as 67 
those based on Mediterranean diet in a pregnant population poses unique methodological and 68 
conceptual challenges.(7,8) The lack of standardised, and accepted methods to evaluate the 69 
effectiveness of dietary interventions may lead to inconsistent findings in nutritional 70 
epidemiology. Factors such as participants’ adherence to the intervention and the accuracy of 71 
the dietary assessment methods could also affect the study findings.(9)  72 
We undertook a multicentre randomised trial (ESTEEM) to assess the effectiveness of a 73 
Mediterranean based diet intervention to reduce complications in pregnant women with 74 
metabolic risk factors. In this article we highlight the methodological challenges and the 75 
lessons learned from the ESTEEM study. 76 
 77 
Methods: 78 
Study design  79 
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ESTEEM is a randomised trial embedded in a cohort study. Recruitment started in September 80 
2014 and finished in February 2016 in five tertiary maternity units in the UK (covering 81 
30,000 deliveries per year). We included pregnant women who met the following criteria: at 82 
least 16 years of age, BMI between 18.5 Kg/m2 and 40 Kg/m2, singleton pregnancy of 18 83 
weeks gestation or less, good understanding of written and spoken English, able to consume 84 
nuts and olive oil and follow a Mediterranean diet lifestyle. We randomised eligible women 85 
with metabolic risk factors (raised serum triglycerides (≥1.7 mmol/L), obesity (BMI ≥30 86 
Kg/m2), or chronic hypertension (≥140mm Hg systolic or ≥90 mm Hg diastolic blood 87 
pressure)) to the ESTEEM dietary intervention or routine antenatal dietary care. Participants 88 
with no metabolic risk factors were followed up in the cohort group and only outcome data 89 
were collected (Figure 1). The primary outcome is a composite maternal outcome defined as 90 
pre-eclampsia (new onset or superimposed) or gestational diabetes; and a fetal composite 91 
outcome defined as stillbirth, small for gestational age fetus (birth weight less than 10th 92 
centile) or admission to the neonatal intensive care unit. The full protocol of the ESTEEM 93 
study has been reported previously (10). 94 
 95 
The ESTEEM dietary intervention is based on Mediterranean diet lifestyle with education to 96 
modify lifestyle choices. The key components of the diet included high intake of fruit and 97 
vegetables, non-refined grains, legumes; moderate to high consumption of fish; small to 98 
moderate intake of poultry and dairy products such as yoghurt and cheese; low consumption 99 
of red meat and processed meat and avoidance of sugary drinks, fast food and food rich in 100 
animal fat. In particular, ESTEEM promoted high intake of nuts (including walnuts, 101 
hazelnuts, and almonds estimated at 30 g/day) and high intake of extra virgin olive oil as the 102 
main source of fat (estimated at 0.5 L/week). The intervention also included dietary education 103 
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sessions, grocery shopping advice, cooking recipes for a healthy diet and advice for 104 
appropriate meal choices at restaurants. 105 
Randomised participants were also consented to collect umbilical cord samples after delivery 106 
to be used for future research on the effect of the dietary intervention on fetal biochemical 107 
outcomes.  108 
 109 
We expected the ESTEEM dietary intervention to reduce the incidence of the composite 110 
primary outcome by 30%, assuming a 24% background risk in our population.  Allowing for 111 
a 20% dropout, the sample size required is 1230 eligible women to ensure an 80% power at 112 
the 5% significance level for maternal and fetal composite outcomes. ESTEEM has 113 
completed its recruitment and currently in the follow up phase.   114 
 115 
Challenges and solutions 116 
Recruitment  117 
The initially planned recruitment period was 14 months. However, this was proven to be 118 
insufficient after the pilot phase given the large sample size required and the slower than 119 
expected recruitment rate. After discussion with the trial steering committee (TSC) we 120 
resolved to extend the recruitment period by further four months, and increased the number 121 
of recruitment centres from three to five major tertiary maternity units in the UK (4 in 122 
London and 1 in Birmingham). We opened sites in a step wise approach, which enabled us to 123 
test and troubleshoot recruitment challenges at each site prior to opening another site. This 124 
allowed us to allocate the trial resources judiciously and to factor in the relatively long 125 
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intervention and follow up periods for each participant.(11) The recruitment centres were 126 
closed in a similar fashion based on a forecast of recruitment figures and staff allocation.  127 
 128 
We implemented a series of evidence-based measures designed to embed the trial recruitment 129 
and follow-up process into clinical practice at the ESTEEM sites.(12) We provided research 130 
training to clinical midwives in groups and individually with the objective to enable them to 131 
recruit and consent participants alongside routine antenatal care. Clinical staff engagement in 132 
ESTEEM was promoted with a series of talks and interactive teaching sessions on the 133 
benefits of involving patients in research studies. We recognised the contribution of our top 134 
recruiting midwives at each of the sites with acknowledgment certificates, dissemination in 135 
newsletters and research meetings, and awarded small financial incentives. We attached an 136 
additional ESTEEM eligibility sheet to all booking clinical notes to remind clinical staff to 137 
recruit booking women. A team of dedicated research staff provided daily support in the 138 
antenatal clinics to help screen and recruit women at their booking visit. Participants who 139 
required additional time to consider the trial before consenting were followed up with 140 
telephone calls by our team. Overall clinical midwives consented a third of participants 141 
recruited into ESTEEM.   142 
 143 
Intervention 144 
In ESTEEM, we focused on delivering the intervention early in the pregnancy to promote the 145 
dietary effect on healthy placentation and reduce metabolic risk factors. We initially planned 146 
to deliver the intervention by 18 weeks gestation. However, this was not always possible, as 147 
many participants were not able to attend their initial appointment. Taking a pragmatic 148 
approach, and reflecting on clinical practice, following our pilot phase we decided to extend 149 
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the intervention window till 20 weeks gestation. This ensured that participants who were 150 
attending for their 20 weeks detailed ultrasound scan were involved in the intervention 151 
delivery process.  152 
 153 
Engagement 154 
Participants’ beliefs and food culture are major confounders in such trials particularly in 155 
pregnant women.(13) Engaging participants in the planning of the intervention is advised to 156 
ensure higher adherence to the intervention.(14) Traditionally, women are advised to ‘’eat for 157 
two’’ and the health benefits of certain food groups are overrated.(15)  Mothers are also more 158 
likely to follow advice from peers, partners and family members compared to health care 159 
professionals.(16) We actively involved our participants in the design and the implementation 160 
of the required dietary changes. Dietary interventions based on the social cognitive theory 161 
have been shown to be effective to improve compliance.(17) Building on this, we delivered a 162 
number of educational sessions to boost the participants’ knowledge on nutrition in 163 
pregnancy on topics  such portion sizes and the benefits of Mediterranean diet to both mother 164 
and baby. We also prompted participants to share experiences and success stories with each 165 
other to improve adherence to the intervention. Additionally, we involved partners and the 166 
whole family where possible to improve adherence particularly in larger families where 167 
pregnant women may not do the shopping and the cooking for the entire household. We 168 
encouraged participants to set personalised goals based on the SMART model (specific, 169 
measurable, achievable, relevant and time specific) to create a personalised working plan and 170 
implement the recommended dietary changes in their lifestyle.  171 
 172 
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purchasing extra virgin olive oil and nuts may be too expensive to some of our participants in 173 
the intervention group, which could affect adherence.(18) We tackled this by providing 174 
regular supply of extra virgin olive oil to cook for the whole family, and sachets of nuts 175 
(walnuts, hazelnuts, and almonds) for personal use throughout the pregnancy.  176 
 177 
We planned the following two intervention sessions (at 20 and 28 weeks) in a group setting 178 
for both the participants and their partners. The aim of these sessions was to provide further 179 
knowledge on the benefits of Mediterranean diet, healthy shopping habits, reading food labels 180 
and beneficial food for the baby. The sessions also aimed to support the participants by 181 
exploring obstacles arising and sharing experiences.(16) Planning these sessions was not 182 
always possible in a group setting and often took place with only one or two participants. For 183 
those participants who missed a session or two we attempted to reschedule or arranged to 184 
send them the nuts and extra virgin olive oil by post to ensure they maintain their intake and 185 
compliance with the intervention.  186 
 187 
Assessing adherence to dietary intervention 188 
Accurate estimation of participants’ basal dietary intake was required before introducing the 189 
intervention.(7) We therefore used the multi-pass 24 hour dietary recall technique combined 190 
with a series of focused questions to carefully assess the participant’s dietary habits at 191 
baseline.(19) This helped our dieticians to identify areas for improvement and the necessary 192 
changes towards adopting a Mediterranean based diet. 193 
 194 
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Our population consisted mainly of multiparous women, often from a transiently immigrant 195 
background. Many of our participants had low literacy of English language, and had 196 
difficulties to complete a complex tool such as weighted food diaries.(20) Using such a 197 
labour intensive tool was particularly not ideal for the majority of our participants looking 198 
after large families and in full time employment.(8) Since our main objective was to 199 
primarily quantify the participants’ adherence to the planned intervention we decided to use a 200 
short 12 items food questionnaire focused that captured the main elements of a Mediterranean 201 
diet (The ESTEEM Q).  202 
 203 
We adapted the ESTEEM Q from a similar questionnaire that was validated in a 204 
Mediterranean non-pregnant population.(21) We amended the our questionnaire by removing 205 
two questions that were not applicable to our population (alcohol intake and sofrito, a tomato 206 
sauce made of a combination of tomato, olive oil, garlic, and onion) consumption) and added 207 
7 dichotomous questions to investigate conditions specific to pregnancy that could affect the 208 
participants’ dietary intake. We used a point scoring scale to assess adherence to the 209 
Mediterranean diet based intervention using previously validated cut-off values. (22)  210 
We intended to use the number of retained empty packets of nuts and extra virgin olive oil as 211 
a marker of participants’ consumption. However, we aborted the use of this method due to 212 
poor returns. The use of specific biomarkers such as alpha-linolenic acids for nuts intake and 213 
hydroxytyrosol for olive oil was another possibility to objectively assess nutrients’ 214 
intake.(23) Using biomarkers  has a number of limitations; they are expensive, invasive and 215 
provide only a snap shot view of the dietary consumption.(23) Taking into account the extra 216 
cost required, we opted to drop the use of biomarkers. 217 
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Given the above limitations we decided to assess the adherence to the intervention by 218 
evaluating the number of attended intervention sessions and comparing the scores obtained 219 
from the ESTEEM Q. 220 
 221 
Control group 222 
Selecting appropriate control subjects in dietary trials is often challenging in clinical settings 223 
(24). There is no clear guideline on what constitute a suitable control population for 224 
interventional dietary studies in pregnancy. In line with ESTEEM’s pragmatic design, we 225 
decided to not impose any dietary requirement on our control group and provided usual 226 
antenatal care as per the national guidelines within the national health service. (25)  227 
 228 
The pragmatic design of ESTEEM provides higher external validity to assess the 229 
effectiveness of the dietary intervention. Our population has diverse ethnic backgrounds with 230 
different food cultures, some of whom might be adopting a Mediterranean lifestyle already. 231 
Many participants were from transiently immigrant families with likely varying food habits. 232 
This could affect the validity of comparing dietary outcomes between the two groups 233 
 234 
Assessment of outcomes  235 
ESTEEM was designed as a pragmatic trial to assess the effectiveness of dietary intervention 236 
on composite maternal and fetal outcomes in clinical practice. We used a robust method to 237 
identify the components of the composite outcome based on a multi-stage modified Delphi 238 
survey of clinical and academic experts in obesity research in pregnancy.(26) Both pre-239 
eclampsia and gestational diabetes were prioritised to be the most clinically important 240 
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maternal outcomes and were included in the composite primary outcome. Our panel of 241 
experts identified stillbirth, small for gestational age fetus (birth weight less than 10th centile) 242 
and admission to the neonatal intensive care unit to be the most clinically important 243 
fetal/neonatal outcomes and were incorporated into the composite outcome. We also decided 244 
to report on each of these outcomes individually as secondary outcomes. Reporting on dietary 245 
outcomes was restricted to the information collected in the ESTEEM Q.  246 
 247 
Complete outcome collection after delivery was logistically challenging within the allocated 248 
time window. We dedicate a research midwife to screen the labour and postnatal wards daily 249 
for any ESTEEM patients in order to capture all new deliveries. We also crosschecked daily 250 
hospital admission records against our electronic records of the participants estimated 251 
delivery date to reduce loss to follow ups.  252 
 253 
Collecting cord blood samples proved to be very demanding in terms of time and resources. 254 
We sought help from clinical midwives on the delivery suite to assist in collecting and 255 
reserving cord blood samples as per the ESTEEM protocol. We produced special ESTEEM 256 
stickers on the participants’ maternity notes and wall posters on delivery suit to remind our 257 
midwives to collect the cord blood samples for eligible participants.(27) 258 
Table (1) provides a summary of encountered challenges and applied solutions in ESTEEM. 259 
 260 
Discussion 261 
The notion that pregnancy could offer a unique window of opportunity to invoke change in 262 
mothers’ lifestyle has inspired many researchers in recent years. However, to date, the 263 
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recorded success remains limited.(5) This is often attributed to the poor quality of available 264 
evidence and small sample sizes. Methodological deficiencies affect the effect size and the 265 
transferability of trial findings into clinical practice. Elements such as the timing of 266 
introducing the intervention in pregnancy, choice of population, compliance and dietary 267 
assessment methods are all important factors to consider when designing diet based 268 
interventional studies.(8)  269 
 270 
The ESTEEM study was focused on evaluating the effectiveness of increased maternal intake 271 
of unsaturated fatty acids early in reducing metabolic disorders in pregnancy namely 272 
gestational diabetes and preeclampsia. The knowledge about the fatty acid disposition in 273 
pregnancy and role of the placenta in the metabolic changes is still somewhat limited.(28) 274 
Our theory is that a high intake of poly unsaturated fatty acids and mono unsaturated fatty 275 
acids will improve the endothelial function, reduce oxidative stress and reduce insulin 276 
resistance thus reducing metabolic risk factors. Obese mothers tend to develop higher 277 
concentration of plasma lipids such as triglycerides and very low-density lipoprotein 278 
throughout pregnancy. However, the levels of unsaturated fatty acids remain stable at pre-279 
pregnancy levels.(29) Altering the maternal diet could help to increase the levels of these 280 
useful nutrients and amplify their role in reducing oxidative stress.(30) The design of the 281 
ESTEEM study will provide pragmatic evidence on the role of Mediterranean diet in 282 
improving pregnancy outcomes in clinical practice.  283 
 284 
To date, our knowledge on the potential long term benefits of dietary intervention in 285 
pregnancy remains limited, in contrast to the proven adverse effect of obesity on long term 286 
maternal and childhood outcomes.(31,32) Nutritional studies should aim to engage 287 
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randomised postpartum cohorts in long term follow-up studies to evaluate long term health 288 
outcomes and retention of the intervention after pregnancy. 289 
 The maintenance of the intervention in the population and the prevalence of healthy lifestyle 290 
after the trial lifetime are also poorly investigated (5); often due to funding and resources 291 
limitations. Advances in dietetics’ technology could help to address this challenge in future 292 
studies at low cost. The use of mobile apps and internet based interventions has been reported 293 
to be helpful in maintaining diabetic control and other chronic diseases.(33,34) Such methods 294 
could significantly help to gather more individualised and long term health outcomes.  295 
 296 
Exploring the qualitative aspect in interventional trials is an important aspect to better 297 
develop and implement lifestyle interventions is. Qualitative research can help to gather more 298 
information on mothers views and attitude towards changing their lifestyle before, during and 299 
after pregnancy.(35) This is particularly helpful to explore potential obstacles to changing 300 
dietary habits in certain subgroups such as participants of low socio-economic status.(36)  301 
 302 
Our knowledge about dietary interventions around pregnancy has evolved markedly in the 303 
last few years. However, several methodological challenges still persist. Innovative and 304 
creative research methods are needed to address this important public health issue.  305 
 306 
Conclusion:  307 
Dietary lifestyle interventions in pregnancy are associated with a number of methodological 308 
challenges. The ESTEEM experience offers an insight into future pragmatic nutritional 309 
studies in pregnancy. 310 
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Table (1): Summary of challenges and solutions proposed in the ESTEEM study.  
 
Domain Challenge Solution 
Recruitment Large sample size and slow 
recruitment rate 
Extended recruitment by 4 months and opened more 
recruitment centres. 
 
 
 Engaged clinical staff in the recruitment and follow 
up process 
 
 
 Assigned dedicated research staff to screen antenatal 
clinics daily 
 
Delivery of the 
intervention 
Poor attendance to initial 
intervention sessions 
Extended the intervention window up to 20 weeks 
gestation 
 
Participants engagement 
with the study 
Various food cultures and 
dietary habits among 
participants 
Tailored intervention based on individual food habits 
assessment 
 
Improve adherence to the 
intervention 
Actively engaged participants and their families in 
planning the required dietary changes to comply with 
the intervention 
 
 
 Provided group dietary educational sessions 
 
 
 Provided nuts and extra virgin olive oil throughout 
the pregnancy 
 
Adherence to the 
intervention 
Assessing basal dietary intake Used of a multi-pass 24 hour dietary recall with 
focused questions 
 
 
Choice of dietary assessment 
tool 
Developed and validated a user friendly short dietary 
questionnaire specific to Mediterranean diet 
 
Control group Choice of control participants Adopted a pragmatic approach with no specific 
dietary requirement in the control group 
 
Outcomes Choice of primary outcome Developed a composite outcome of maternal and 
fetal outcomes prioritised by a panel of experts. 
 
 
Complete outcome collection Assigned dedicated research staff to screen postnatal 
and labour ward and crosscheck participants against 
electronic records 
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Figure (1): ESTEEM study design including the screening, recruitment and randomisation 
process. 
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